Neutralising antibody activity against SARS-CoV-2 variants, including Omicron, in an elderly cohort vaccinated with BNT162b2

Joseph Newman, Nazia Thakur, Thomas P. Peacock, Dagmara Bialy, Ahmed ME Elreafey, Carlijn Bogaardt, Daniel L. Horton, Sammy Ho, Thivya Kankeyan, Christine Carr, Katja Hoschler, Wendy S. Barclay, Gayatri Amirthalingam, Kevin Brown, Bryan Charleston, Dalan Bailey
doi: https://doi.org/10.1101/2021.12.23.21268293

Article usage

Article usage: December 2021 to June 2023

AbstractFullPdf
Dec 202113283635
Jan 202272844451
Feb 20221674083
Mar 20221491372
Apr 202289848
May 202285235
Jun 2022118637
Jul 20221241118
Aug 202242214
Sep 202269212
Oct 202257411
Nov 202233115
Dec 20223949
Jan 202377111
Feb 202345621
Mar 20232715
Apr 202331106
May 20231924
Jun 2023711
Back to top
Posted December 24, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Neutralising antibody activity against SARS-CoV-2 variants, including Omicron, in an elderly cohort vaccinated with BNT162b2
Joseph Newman, Nazia Thakur, Thomas P. Peacock, Dagmara Bialy, Ahmed ME Elreafey, Carlijn Bogaardt, Daniel L. Horton, Sammy Ho, Thivya Kankeyan, Christine Carr, Katja Hoschler, Wendy S. Barclay, Gayatri Amirthalingam, Kevin Brown, Bryan Charleston, Dalan Bailey
medRxiv 2021.12.23.21268293; doi: https://doi.org/10.1101/2021.12.23.21268293
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area